Page last updated: 2024-11-03

ono 1078 and Acute Disease

ono 1078 has been researched along with Acute Disease in 6 studies

pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist

Acute Disease: Disease having a short and relatively severe course.

Research Excerpts

ExcerptRelevanceReference
"Conventional treatment for acute otitis media mainly targets bacteria with antibiotics, neglecting to control for mediators of inflammation."2.82The effect of the leukotriene antagonist pranlukast on pediatric acute otitis media. ( Esaki, S; Hamajima, Y; Miyamoto, N; Murakami, S; Nakamura, Y; Nakayama, M; Oshika, M; Sugiyama, K; Suzuki, M; Takagi, I; Yasui, K; Yokota, M, 2016)
"Acute pancreatitis was induced in rats by intravenous infusion of a supramaximal dose of cerulein (5 micrograms/kg h for 4 h)."1.30Peptide leukotriene receptor antagonist diminishes pancreatic edema formation in rats with cerulein-induced acute pancreatitis. ( Hirano, T, 1997)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shi, QJ1
Wang, H1
Liu, ZX1
Fang, SH1
Song, XM1
Lu, YB1
Zhang, WP1
Sa, XY1
Ying, HZ1
Wei, EQ1
Nakamura, Y1
Hamajima, Y1
Suzuki, M1
Esaki, S1
Yokota, M1
Oshika, M1
Takagi, I1
Yasui, K1
Miyamoto, N1
Sugiyama, K1
Nakayama, M1
Murakami, S1
Matsuse, H1
Kondo, Y1
Machida, I1
Kawano, T1
Saeki, S1
Tomari, S1
Obase, Y1
Fukushima, C1
Mizuta, Y1
Kohno, S1
Hirano, T1
Schurman, SJ1
Alderman, JM1
Massanari, M1
Lacson, AG1
Perlman, SA1
Takahashi, N1
Iwanaga, T1
Aizawa, H1
Koto, H1
Watanabe, K1
Kishikawa, R1
Ikeda, T1
Shoji, S1
Nishima, S1
Hara, N1

Trials

1 trial available for ono 1078 and Acute Disease

ArticleYear
The effect of the leukotriene antagonist pranlukast on pediatric acute otitis media.
    International journal of pediatric otorhinolaryngology, 2016, Volume: 87

    Topics: Acute Disease; Anti-Bacterial Agents; Child; Child, Preschool; Chromones; Disease Progression; Drug

2016

Other Studies

5 other studies available for ono 1078 and Acute Disease

ArticleYear
HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats.
    Neuroscience, 2015, Apr-16, Volume: 291

    Topics: Acute Disease; Animals; Brain; Brain Edema; Brain Ischemia; Chromones; Cyclohexanecarboxylic Acids;

2015
Effects of anti-inflammatory therapies on recurrent and low-grade respiratory syncytial virus infections in a murine model of asthma.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2006, Volume: 97, Issue:1

    Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Antigens, Dermatophagoides; Asthma; Bronchoalveola

2006
Peptide leukotriene receptor antagonist diminishes pancreatic edema formation in rats with cerulein-induced acute pancreatitis.
    Scandinavian journal of gastroenterology, 1997, Volume: 32, Issue:1

    Topics: Acute Disease; Amylases; Animals; Body Water; Cathepsin B; Ceruletide; Chromones; Edema; Leukotriene

1997
Tubulointerstitial nephritis induced by the leukotriene receptor antagonist pranlukast.
    Chest, 1998, Volume: 114, Issue:4

    Topics: Acute Disease; Asthma; Biopsy; Child; Chromones; Creatinine; Follow-Up Studies; Glycosuria; Hematuri

1998
Acute interstitial pneumonia induced by ONO-1078 (pranlukast), a leukotriene receptor antagonist.
    Internal medicine (Tokyo, Japan), 2001, Volume: 40, Issue:8

    Topics: Acute Disease; Anti-Asthmatic Agents; Asthma; Chromones; Diagnosis, Differential; Female; Humans; Le

2001